Literature DB >> 27525548

Levonorgestrel in contraceptives and multipurpose prevention technologies: does this progestin increase HIV risk or interact with antiretrovirals?

Chelsea B Polis1, Sharon J Phillips, Sharon L Hillier, Sharon L Achilles.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27525548      PMCID： PMC5083202          DOI： 10.1097/QAD.0000000000001229

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  35 in total

Review 1.  An update on multipurpose prevention technologies for the prevention of HIV transmission and pregnancy.

Authors:  David R Friend
Journal:  Expert Opin Drug Deliv       Date:  2016-01-22       Impact factor: 6.648

2.  Prospective study of hormonal contraception and women's risk of HIV infection in South Africa.

Authors:  Landon Myer; Lynette Denny; Thomas C Wright; Louise Kuhn
Journal:  Int J Epidemiol       Date:  2006-12-14       Impact factor: 7.196

3.  Hormonal contraception and the risk of HIV acquisition.

Authors:  Charles S Morrison; Barbra A Richardson; Francis Mmiro; Tsungai Chipato; David D Celentano; Joanne Luoto; Roy Mugerwa; Nancy Padian; Sungwal Rugpao; Joelle M Brown; Peter Cornelisse; Robert A Salata
Journal:  AIDS       Date:  2007-01-02       Impact factor: 4.177

4.  Sino-implant (II)® continuation and effect of concomitant tenofovir disoproxil fumarate-emtricitabine use on plasma levonorgestrel concentrations among women in Bondo, Kenya.

Authors:  Catherine S Todd; Jennifer Deese; Meng Wang; David Hubacher; Markus J Steiner; Sheila Otunga; Lut Van Damme
Journal:  Contraception       Date:  2014-10-22       Impact factor: 3.375

5.  Estrogen protects against vaginal transmission of simian immunodeficiency virus.

Authors:  S M Smith; G B Baskin; P A Marx
Journal:  J Infect Dis       Date:  2000-08-08       Impact factor: 5.226

6.  Binding of progestins to the glucocorticoid receptor. Correlation to their glucocorticoid-like effects on in vitro functions of human mononuclear leukocytes.

Authors:  K Kontula; T Paavonen; T Luukkainen; L C Andersson
Journal:  Biochem Pharmacol       Date:  1983-05-01       Impact factor: 5.858

7.  Changes in genital tract immune cell populations after initiation of intrauterine contraception.

Authors:  Sharon L Achilles; Mitchell D Creinin; Kevin A Stoner; Beatrice A Chen; Leslie Meyn; Sharon L Hillier
Journal:  Am J Obstet Gynecol       Date:  2014-05-13       Impact factor: 8.661

8.  Studying the effects of reproductive hormones and bacterial vaginosis on the glycome of lavage samples from the cervicovaginal cavity.

Authors:  Linlin Wang; Sujeethraj Koppolu; Catherine Chappell; Bernard J Moncla; Sharon L Hillier; Lara K Mahal
Journal:  PLoS One       Date:  2015-05-20       Impact factor: 3.240

9.  A 3-year multicentre randomized controlled trial of etonogestrel- and levonorgestrel-releasing contraceptive implants, with non-randomized matched copper-intrauterine device controls.

Authors:  Luis Bahamondes; Vivian Brache; Olav Meirik; Moazzam Ali; Ndema Habib; Sihem Landoulsi
Journal:  Hum Reprod       Date:  2015-09-25       Impact factor: 6.918

10.  The Contribution of Cervicovaginal Infections to the Immunomodulatory Effects of Hormonal Contraception.

Authors:  Raina N Fichorova; Pai-Lien Chen; Charles S Morrison; Gustavo F Doncel; Kevin Mendonca; Cynthia Kwok; Tsungai Chipato; Robert Salata; Christine Mauck
Journal:  MBio       Date:  2015-09-01       Impact factor: 7.867
View more
  9 in total

Review 1.  Hormonal Contraception and HIV-1 Acquisition: Biological Mechanisms.

Authors:  Janet P Hapgood; Charu Kaushic; Zdenek Hel
Journal:  Endocr Rev       Date:  2018-02-01       Impact factor: 19.871

Review 2.  Progesterone-based compounds affect immune responses and susceptibility to infections at diverse mucosal sites.

Authors:  Olivia J Hall; Sabra L Klein
Journal:  Mucosal Immunol       Date:  2017-04-12       Impact factor: 7.313

3.  Effects of intrauterine contraception on the vaginal microbiota.

Authors:  Christine M Bassis; Jenifer E Allsworth; Heather N Wahl; Daniel E Sack; Vincent B Young; Jason D Bell
Journal:  Contraception       Date:  2017-06-15       Impact factor: 3.375

4.  Use of Intrauterine Devices and Risk of Human Immunodeficiency Virus Acquisition Among Insured Women in the United States.

Authors:  Julia L Marcus; Jonathan M Snowden; Mara E Murray Horwitz; Sengwee Toh; Casie Horgan; Rong Chen Tilney; Rajani Rajbhandari; Soowoo Back; Daniel J Westreich
Journal:  Clin Infect Dis       Date:  2020-05-06       Impact factor: 9.079

5.  Brief Report: Dapivirine Vaginal Ring Use Does Not Diminish the Effectiveness of Hormonal Contraception.

Authors:  Jennifer E Balkus; Thesla Palanee-Phillips; Krishnaveni Reddy; Samantha Siva; Ishana Harkoo; Clemensia Nakabiito; Kenneth Kintu; Gonasangrie Nair; Catherine Chappell; Flavia Matovu Kiweewa; Samuel Kabwigu; Logashvari Naidoo; Nitesha Jeenarain; Mark Marzinke; Lydia Soto-Torres; Elizabeth R Brown; Jared M Baeten
Journal:  J Acquir Immune Defic Syndr       Date:  2017-10-01       Impact factor: 3.731

Review 6.  Pharmacokinetics, metabolism and serum concentrations of progestins used in contraception.

Authors:  Alexis J Bick; Renate Louw-du Toit; Salndave B Skosana; Donita Africander; Janet P Hapgood
Journal:  Pharmacol Ther       Date:  2020-12-13       Impact factor: 13.400

7.  Novel multipurpose pod-intravaginal ring for the prevention of HIV, HSV, and unintended pregnancy: Pharmacokinetic evaluation in a macaque model.

Authors:  James M Smith; John A Moss; Priya Srinivasan; Irina Butkyavichene; Manjula Gunawardana; Rob Fanter; Christine S Miller; Debbie Sanchez; Flora Yang; Shanon Ellis; Jining Zhang; Mark A Marzinke; Craig W Hendrix; Amita Kapoor; Marc M Baum
Journal:  PLoS One       Date:  2017-10-05       Impact factor: 3.240

8.  Progestins Related to Progesterone and Testosterone Elicit Divergent Human Endometrial Transcriptomes and Biofunctions.

Authors:  Sahar Houshdaran; Joseph C Chen; Júlia Vallvé-Juanico; Shayna Balayan; Kim Chi Vo; Karen Smith-McCune; Ruth M Greenblatt; Juan C Irwin; Linda C Giudice
Journal:  Int J Mol Sci       Date:  2020-04-09       Impact factor: 5.923

9.  Rational Design of a Multipurpose Bioadhesive Vaginal Film for Co-Delivery of Dapivirine and Levonorgestrel.

Authors:  Jing Li; Galit Regev; Sravan Kumar Patel; Dorothy Patton; Yvonne Sweeney; Philip Graebing; Sheila Grab; Lin Wang; Vinayak Sant; Lisa C Rohan
Journal:  Pharmaceutics       Date:  2019-12-18       Impact factor: 6.321
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.